Skip to main content

Table 4 Mean and standard deviation (SD) on cognitive tests at baseline, 12 months, and change over time

From: Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial

 

Placebo

Simvastatin

Effect size

Baseline

12 months

Change

Baseline

12 months

Change

NADIID

 

Memory for Objects test

5.7 (2.3)

4.9 (2.6)

−0.8 (1.2)

4.0 (2.4)

5.3 (2.7)

1.3 (1.0)

1.0 (0.4, 1.6)

Selective Attention Cancellation Test

 

Overall score

17.0 (9.3)

18.8 (11.6)

1.8 (14.1)

25.3 (25.0)

21.7 (8.4)

−3.7 (22.6)

−0.4 (−2.1, 1.3)

CANTAB pattern recognition memory

 

% Correct

61.5 (23.5)

67.3 (17.4)

5.8 (6.7)

56.6 (12.3)

57.0 (12.2)

0.4 (13.4)

−0.9 (−1.9, 0.1)

Cats and Dogs switching condition

 

Time taken

58.8 (36.3)

47.0 (31.5)

−11.8 (26.3)

40.5 (22.0)

44.0 (10.9)

3.5 (27.4)

0.05 (−1.3, 1.4)

 

Number of errors

4.1 (5.3)

7.0 (8.2)

2.9 (8.6)

11.0 (7.6)

7.8 (7.5)

−3.3 (6.5)

–a

Tower of London Test (revised for learning disabilities)

 

Total score

21.7 (8.5)

24.8 (13.6)

3.1 (11.1)

20.7 (8.0)

20.3 (11.7)

−0.3 (18.4)

−0.7 (−2.3, 0.86)

Cued Recall Test

 

Total score

34.1 (4.5)

28.7 (13.0)

−5.4 (12.7)

21.2 (12.7)

12.8 (14.2)

−8.3 (13.9)

–a

Category Fluency Test

 

Number correct

12.1 (4.2)

9.2 (3.9)

−2.9 (4.4)

8.0 (4.2)

8.2 (6.1)

0.2 (3.5)

0.3 (−1.1, 1.7)

 

Number repeated

0.7 (1.1)

1.0 (1.1)

0.3 (0.9)

2.6 (1.7)

1.6 (1.1)

−1.0 (1.2)

0.5 (−0.2, 1.3)

 

Number of errors

0.3 (0.5)

0.1 (0.3)

−0.2 (0.7)

0.0 (0.0)

0.2 (0.5)

0.2 (0.5)

–a

Story Recall Test

 

Free recall

5.8 (3.7)

3.6 (3.3)

−2.1 (3.2)

5.0 (6.3)

3.0 (4.2)

−2.0 (3.7)

−0.4 (−1.2, 0.4)

 

Cued recall

4.4 (2.7)

3.9 (3.0)

−0.5 (2.9)

2.4 (4.3)

2.6 (3.7)

0.2 (2.3)

−0.6 (−1.8, 0.7)

  1. Effect size reported as estimated between-group difference, adjusted for baseline score and stratification variables, divided by baseline SD in whole population, and reversed where necessary so that a positive effect size corresponds to a benefit for simvastatin group
  2. aThese are logistic models with decline versus no decline as the response; therefore, no effect size is given
  3. CANTAB Cambridge Neuropsychological Test Automated Battery, NADIID Neuropsychological Assessment of Dementia in Individuals with Intellectual Disabilities